Low Sick Pay Is Making Britain Sicker

Why It Matters

Inadequate sick pay forces ill employees to work, spreading disease and increasing long‑term economic inactivity, which threatens productivity and raises health costs.

Key Takeaways

• Statutory sick pay remains £118.75/week (~$150).
• 10% of UK workers worked while ill last year.
• Low pay drives early returns, spreading disease.
• Review linked higher sick pay to lower economic inactivity.
• Labour's 2024 manifesto only eases access, not rate.

Pulse Analysis

The United Kingdom’s statutory sick pay (SSP) has long lagged behind its peers. At £118.75 per week—roughly $150—its value barely outpaces inflation and sits near the bottom of the Organisation for Economic Co‑operation and Development (OECD) rankings. The figure was set in 2022 and has not been adjusted despite rising living costs. While other high‑income nations provide two weeks of near‑full wages, British workers on low‑pay contracts receive a modest flat rate that often fails to cover basic expenses. This structural shortfall has become a focal point for health‑policy analysts and labour unions alike.

The practical consequences are stark. A recent DWP survey, analysed by the Centre for Progressive Change, revealed that 3.7 million employees—about 10 % of the labour force—worked while ill because SSP did not meet their financial needs. Such ‘presenteeism’ fuels contagion, as illustrated by the tuberculosis cluster at an Amazon fulfilment centre in Coventry and the meningitis B outbreak in Kent. Moreover, early returns exacerbate injuries, exemplified by a builder whose hand infection followed a rushed comeback. Economists note that higher SSP levels are linked to reduced long‑term sickness absence, a key driver of the UK’s record‑high economic inactivity rate.

Politically, the issue sits at the intersection of Labour’s 2024 manifesto and the government’s Keep Britain Working review. Labour introduced reforms that remove the three‑day unpaid waiting period and broaden eligibility, yet stopped short of raising the weekly rate. The DWP’s own review dismissed a rate increase, arguing SSP falls outside employer responsibilities, despite evidence that generous sick‑pay schemes curb inactivity. Advocates argue that a modest uplift—aligned with inflation and comparable to EU benchmarks—could lower disease transmission, improve worker health, and ultimately boost productivity. Without such reform, the UK risks perpetuating a cycle of ill‑workers, higher health costs, and a shrinking labour pool.